Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
Epigenetics is closely related to cardiovascular diseases. Genome-wide linkage and
association analyses and candidate gene approaches illustrate the multigenic complexity of …

Signaling effectors underlying pathologic growth and remodeling of the heart

JH Van Berlo, M Maillet… - The Journal of clinical …, 2013 - Am Soc Clin Investig
Cardiovascular disease is the number one cause of mortality in the Western world. The heart
responds to many cardiopathological conditions with hypertrophic growth by enlarging …

Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype

L Lecce, Y Xu, B V'Gangula, N Chandel… - The Journal of …, 2021 - Am Soc Clin Investig
Endothelial-mesenchymal transition (EndMT) is associated with various cardiovascular
diseases and in particular with atherosclerosis and plaque instability. However, the …

[HTML][HTML] NCoR1 is a conserved physiological modulator of muscle mass and oxidative function

H Yamamoto, EG Williams, L Mouchiroud, C Cantó… - Cell, 2011 - cell.com
Transcriptional coregulators control the activity of many transcription factors and are thought
to have wide-ranging effects on gene expression patterns. We show here that muscle …

Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue

A Galmozzi, N Mitro, A Ferrari, E Gers, F Gilardi… - …, 2013 - Am Diabetes Assoc
Chromatin modifications are sensitive to environmental and nutritional stimuli. Abnormalities
in epigenetic regulation are associated with metabolic disorders such as obesity and …

[HTML][HTML] Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions

P Bontempo, L Capasso, L De Masi, A Nebbioso… - Nutrients, 2024 - mdpi.com
Cardiovascular diseases (CVDs) remain a leading global cause of morbidity and mortality.
These diseases have a multifaceted nature being influenced by a multitude of biochemical …

c-Myc modulation and acetylation is a key HDAC inhibitor target in cancer

A Nebbioso, V Carafa, M Conte, FP Tambaro… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Histone deacetylase inhibitors (HDACi) are promising anticancer drugs.
Although some HDACi have entered the clinic, the mechanism (s) underlying their tumor …

Targeting histone deacetylases in diseases: where are we?

R Benedetti, M Conte, L Altucci - Antioxidants & redox signaling, 2015 - liebertpub.com
Significance: Epigenetic inactivation of pivotal genes involved in cell growth is a hallmark of
human pathologies, in particular cancer. Histone acetylation balance obtained through …

1, 3, 4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells

S Valente, D Trisciuoglio, T De Luca… - Journal of medicinal …, 2014 - ACS Publications
We describe 1, 3, 4-oxadiazole-containing hydroxamates (2) and 2-aminoanilides (3) as
histone deacetylase inhibitors. Among them, 2t, 2x, and 3i were the most potent and …

Specific control of pancreatic endocrine β-and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9

O Lenoir, K Flosseau, FX Ma, B Blondeau, A Mai… - Diabetes, 2011 - Am Diabetes Assoc
OBJECTIVE Class IIa histone deacetylases (HDACs) belong to a large family of enzymes
involved in protein deacetylation and play a role in regulating gene expression and cell …